Compugen Ltd. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
CGEN Nasdaq 2836 cgen.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Compugen Ltd.

Compugen Ltd (CGEN) Q1 2026 Earnings Call Highlights: Strategic Advances Amid Financial Challenges - May 25th, 2026 7:01 pm
Compugen Q1 Earnings Call Highlights - May 18th, 2026 8:08 am
Compugen (CGEN) Reports Q1 Loss, Lags Revenue Estimates - May 18th, 2026 7:00 am
Compugen surges after revenue tops forecasts despite quarterly loss miss (CGEN) - May 18th, 2026 6:35 am
Compugen Reports First Quarter 2026 Results - May 18th, 2026 5:00 am
BioXcel Therapeutics, Inc. (BTAI) Reports Q1 Loss, Lags Revenue Estimates - May 15th, 2026 6:15 am
Adherex Technologies Inc. (FENC) Beats Q1 Earnings and Revenue Estimates - May 14th, 2026 5:40 am
Compugen to Participate in 2026 Stifel Virtual Targeted Oncology Forum - May 12th, 2026 5:00 am
Janux Therapeutics, Inc. (JANX) Reports Q1 Loss, Lags Revenue Estimates - May 7th, 2026 5:05 pm
BioMarin Pharmaceutical (BMRN) Q1 Earnings Lag Estimates - May 4th, 2026 3:20 pm
Compugen to Release First Quarter 2026 Results on Monday, May 18, 2026 - May 4th, 2026 5:00 am
Compugen Highlights AI-Driven IO Pipeline, Key Trial Timelines and Big Pharma Partnerships at Needham Conference - Apr 13th, 2026 10:34 am
Compugen to Participate in 25th Annual Needham Virtual Healthcare Conference - Apr 9th, 2026 5:00 am
Compugen Ltd. (CGEN) Reports Q4 Revenue of $67.3 Million vs. $1.5 Million Last Year - Mar 12th, 2026 1:38 am
Compugen Ltd (CGEN) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Mar 3rd, 2026 6:03 pm
Compugen Ltd. Q4 2025 Earnings Call Summary - Mar 2nd, 2026 10:31 am
Compugen (CGEN) Beats Q4 Earnings and Revenue Estimates - Mar 2nd, 2026 6:15 am
Compugen: Q4 Earnings Snapshot - Mar 2nd, 2026 5:17 am
Compugen Reports Fourth Quarter and Full Year 2025 Results - Mar 2nd, 2026 5:00 am
Kymera Therapeutics, Inc. (KYMR) Reports Q4 Loss, Misses Revenue Estimates - Feb 26th, 2026 7:55 am